Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

LEXX Lexaria Bioscience Corporation

2,66

0,07 (2,70%)

Vor Marktöffnung

Zuletzt aktualisiert: 14:27:05

Verzögert um 15 Minuten

Form S-8 - Securities to be offered to employees in employee benefit plans

nullnullnullnullnullnull

Lexaria Bioscience (NASDAQ:LEXX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Lexaria Bioscience Charts.

Lexaria Bioscience (NASDAQ:LEXX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Lexaria Bioscience Charts.

News Lexaria Bioscience Corporation

Form DEF 14A - Other definitive proxy statements
Mittwoch 6 März 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 1 März 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 16 Februar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form D - Notice of Exempt Offering of Securities
Freitag 16 Februar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mittwoch 14 Februar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 30 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 24 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Mittwoch 24 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Donnerstag 18 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Freitag 12 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Drug-Delivery System Improves Way Molecules Enter Bloodstream
Donnerstag 11 Januar 2024 (5 Monate vor) • GlobeNewswire Inc.

Weitere Lexaria Bioscience Corporation News-Artikel

Invesco QQQ Trust Series 1

Financial Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen